// App-Quantinova.ai

e15523 : Global BRAF testing practices in metastatic colorectal cancer (mCRC).

Researchers

Presenter

  • Jayesh Desai

Principal Investigators

  • Scott Kopetz

  • Axel Grothey

  • Fortunato Ciardiello

  • Tae Won Kim

  • Tim Maughan

  • Eric Van Cutsem

  • Harpreet Singh Wasan

  • Rona Yaeger

  • Takayuki Yoshino

  • Ashwin Gollerkeri

  • Michelle L. Edwards

  • Montessa Rodriguez Lizaso

  • Josep Tabernero

Medical Centers

  • Peter MacCallum Cancer Centre, East Melbourne, Australia

  • 1.MD Anderson Cancer Center, Houston, TX

  • West Cancer Center, OneOncology, Germantown, TN, University of Campania Luigi Vanvitelli, Naples, Italy

  • Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

  • Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom

  • University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium

  • Hammersmith Hospital, Division of Cancer, Imperial College London, London, United Kingdom

  • Memorial Sloan Kettering Cancer Center, New York, NY, National Cancer Center Hospital East, Kashiwa, Japan

  • AstraZeneca, Gaithersburg, MD, Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology (VHIO), UVic-UCC, Barcelona, Spain

Locations

  • Australia

  • Italy

  • United Kingdom

  • Belgium

  • Japan

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Colorectal Cancer

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

Drug/Treatment

  • Encorafenib

  • Erbitux

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A